Gene effects benefit of breast-cancer drug
17th Dec 2005, 12:19 GMT
Washington, A recent research has found that the beneficiary effects of tamoxifen, one of the most commonly administered drugs for breast cancer, may not be as effective in women who inherit a common genetic change which affects the levels of a crucial liver enzyme.
Gene effects benefit of breast-cancer drug related news:
- Gene variation affects tamoxifen's benefit for breast cancer — EurekAlert! - Cancer
- Aromatase inhibitor shows promise for breast cancer patients — The Cancer Blog
- Novartis drug helps prevent breast cancer recurrence — Pharmaceutical Business Review Online
- Mayo Clinic reports tamoxifen benefit for breast-cancer patients tied to inherited gene — EurekAlert! - Cancer
- Breast cancer gene tests backlog — the Mail online | Health news
- Breast cancer drug may work in lung cancer — United Press International - Health Business
- Survival Benefit For Arimidex™ In Early Breast Cancer — Medical News Today RSS/XML Feed
- Gene change inhibits tamoxifen -- study — United Press International - Health Business
- More good news - Femara helps prevent the return of breast cancer — News-Medical News Feed
- NHS under pressure to provide new breast cancer drugs — News-Medical News Feed
Latest news from KeralaNext: Health:
- In Heart Patients Smoking related to Cognitive Decline
- Tool Helps to Predicts Post-Surgery Breast Cancer Recurrence
- Breath Test help to predict Lung Cancer; Scientists
- Study Emphasizes Older Women's Risk for bone fractures
- Scientists discovered Anti-Cancer Compound in Green Tea
- Tea could block the spread of HIV
- Stem cells give hope for diabetes cure
- Study says, Late-life pregnancies risky, but birth outcomes are good
- Over 300,000 drug Lankans hooked
- Study says, Red meat connected to some breast cancers